昊海生物科技(06826)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06826 昊海生物科技

劳动节休市 04-30 16:08:11

22.120

-0.460

-2.04%

最高22.540	最低22.100	成交量8.58万
今开22.520	昨收22.580	日振幅1.95%
总市值50.88亿	流通市值7.95亿	总股本2.30亿
成交额191.04万	换手率0.24%	流通股本3,593万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06826","market":"HK","secType":"STK","nameCN":"昊海生物科技","latestPrice":22.12,"timestamp":1777536491457,"preClose":22.58,"halted":0,"volume":85800,"delay":0,"changeRate":-0.020372010628874993,"floatShares":35929000,"shares":229999999,"eps":1.2384188422603193,"marketStatus":"劳动节休市","change":-0.46,"latestTime":"04-30 16:08:11","open":22.52,"high":22.54,"low":22.1,"amount":1910446,"amplitude":0.019486,"askPrice":22.2,"askSize":300,"bidPrice":22.1,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":1.160937396731125,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777858200000},"marketStatusCode":7,"adr":0,"listingDate":1430323200000,"exchange":"SEHK","adjPreClose":22.58,"dividendRate":0.051768,"openAndCloseTimeList":[[1777512600000,1777521600000],[1777525200000,1777536000000]],"volumeRatio":0.30803917620917237,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688366","market":"SH","secType":"STK","nameCN":"昊海生科","latestPrice":39.65,"timestamp":1777532400000,"preClose":39.68,"halted":0,"volume":445700,"delay":0,"premium":"-51.35"}},"requestUrl":"/m/hq/s/06826","defaultTab":"news","newsList":[{"id":"2631463758","title":"昊海生物科技(06826)：公司控股股东、实际控制人之一蒋伟因非本公司事项收到《取保候审决定书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2631463758","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631463758?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:38","pubTimestamp":1777552710,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技 发布公告，于近日收到控股股东、实际控制人之一蒋伟先生通知，因蒋伟先生涉嫌内幕交易案侦查所需，上海市公安局出具了《取保候审决定书》，决定对蒋伟先生取保候审，期限从2026年4月29日起算。具体内容详见公司于2025年12月24日在上海证券交易所网站披露的《上海昊海生物科技股份有限公司关于公司控股股东、实际控制人之一因非本公司事项收到<行政处罚决定书>的公告》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437480.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1593","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145962005","title":"昊海生物科技4月29日回购11.25万股H股，耗资约251.94万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145962005","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145962005?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:07","pubTimestamp":1777453663,"startTime":"0","endTime":"0","summary":"2026年4月29日，上海昊海生物科技股份有限公司发布翌日披露报表，披露当日于香港联交所场内回购H股股份，本次回购股份数量为112,500股。根据公告，本次回购股份数量占公司当前已发行股本约0.0497%，每股回购价格区间为港币22.24元至22.58元，合计支付对价为港币2,519,442元，折合约251.94万港元。由于上述回购股份尚未注销，公司H股已发行股份仍为35,929,040股，A股已发行股份为190,203,760股，库藏股份为3,848,095股，合计普通股仍为226,132,800股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昊海生物科技4月29日回购11.25万股H股，耗资约251.94万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178823748","title":"昊海生物科技：4月28日回购18.06万股H股，耗资约401.59万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1178823748","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178823748?lang=zh_cn&edition=full","pubTime":"2026-04-28 18:11","pubTimestamp":1777371101,"startTime":"0","endTime":"0","summary":"2026年4月28日，上海昊海生物科技股份有限公司公告称，当日于香港联交所回购H股共计18.06万股，最高回购价为每股22.40港元，最低回购价为每股21.92港元，合计耗资约401.59万港元。该回购股份占公司已发行股本约0.0799%。目前，公司已发行股本总数维持在226,132,800股，其中包括190,203,760股A股及35,929,040股H股。截至公告日，公司已累计回购3,179,700股，占授权决议通过当日公司已发行股本数目的8.1235%。公司表示，其已遵守香港联交所上市规则及其他相关法例的要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昊海生物科技：4月28日回购18.06万股H股，耗资约401.59万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630937793","title":"昊海生物科技(06826)4月28日斥资401.59万港元回购18.06万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630937793","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630937793?lang=zh_cn&edition=full","pubTime":"2026-04-28 18:09","pubTimestamp":1777370997,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，该公司于2026年4月28日斥资401.59万港元回购18.06万股股份，每股回购价格为21.92-22.4港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06826","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111074225","title":"昊海生物科技将于2026年派发末期股息每股0.60元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111074225","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111074225?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:36","pubTimestamp":1777369019,"startTime":"0","endTime":"0","summary":"昊海生物科技(06826)宣布，董事会已就截至2025年12月31日止年度建议派发末期股息每股人民币0.60元，须待股东于2026年5月29日批准后发放。公司同时披露，具体派息金额将以港元发放，汇率及实际发放日期有待公布。\n根据公告，除净日为2026年6月4日，股权登记截止时间为2026年6月5日16时30分，股份过户登记处将于2026年6月8日至6月11日暂停办理过户，2026年6月11日为登记日期。公司指出，在派发本次股息时，将按所属股东类别及适用税率代扣相关所得税，更多详细信息以公司公告及股东大会通函为准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昊海生物科技将于2026年派发末期股息每股0.60元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630237170","title":"昊海生物科技(06826)拟派发末期股息每股0.6元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630237170","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630237170?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:32","pubTimestamp":1777368756,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，该公司拟派发末期股息每股0.6元人民币。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435314.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","VIG","BK1593","06826","BK1161","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141507240","title":"昊海生物科技将授予董事会股份购回授权，规模最高可达已发行H股一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1141507240","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141507240?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:02","pubTimestamp":1777366940,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司发布公告，董事会提议于2026年5月29日召开的股东大会及同日举行的A股和H股类别股东大会上，审议向董事会授出股份购回的一般性授权，拟在相关授权期间内，根据适用法律法规，择机以不超过公司已发行H股总数10%的规模进行回购。公告显示，截至最新可行日期，该公司拥有约3,580,724股H股的可回购上限数额。此外，为配合会议投票，公司将于5月26日至5月29日暂停办理H股股份过户登记。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昊海生物科技将授予董事会股份购回授权，规模最高可达已发行H股一成","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139634379","title":"昊海生物科技：2026年4月27日回购27.71万股，耗资约597.09万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1139634379","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139634379?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:00","pubTimestamp":1777284009,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司于2026年4月27日披露公告，称该公司当日在香港联交所场内回购H股27.71万股，回购价格介乎每股港币21.40元至21.70元，总金额约港币597.09万元。本次回购股份占截至回购前公司已发行股份总数的约0.1225%。截至2026年4月27日，公司已发行股本仍维持在普通股226,132,800股，其中包括190,203,760股A股及35,929,040股H股。根据此前于2025年6月10日获股东大会通过的购回授权，公司可回购股份总数为3,914,184股，截至目前已合计购回股份2,999,100股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昊海生物科技：2026年4月27日回购27.71万股，耗资约597.09万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630436420","title":"昊海生物科技(06826)4月27日耗资约597.09万港元回购27.71万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630436420","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630436420?lang=zh_cn&edition=full","pubTime":"2026-04-27 17:52","pubTimestamp":1777283548,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)公布，2026年4月27日耗资约597.09万港元回购27.71万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434489.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","06826","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629840935","title":"昊海生物科技(06826)一季度归母净利润7355.9万元，同比下降18.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629840935","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629840935?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:19","pubTimestamp":1777040359,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布2026年第一季度报告，营业收入5.71亿元，同比下降7.62%;归属于上市公司股东的净利润7355.9万元，同比下降18.55%;基本每股收益0.32元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433781.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168523858","title":"昊海生物科技2026年第一季度营收5.71亿元，经调整净利润5813.18万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1168523858","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168523858?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:16","pubTimestamp":1777040184,"startTime":"0","endTime":"0","summary":"根据公司公告，昊海生物科技2026年第一季度实现营收约5.71亿元，同比下降7.62%。经调整净利润为5813.18万元，同比下降34.30%。经营活动产生的现金流量净额约为1857.42万元，同比下滑78.37%。研发投入约为5198.74万元，同比增加7.37%，占营业收入比例为9.10%。报告期内，公司受到国内消费需求不足和产品价格竞争的影响，高毛利产品销售承压，整体收入及利润水平均出现一定幅度下滑。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昊海生物科技2026年第一季度营收5.71亿元，经调整净利润5813.18万元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163269424","title":"昊海生物科技2025年收入下滑至24.46亿元 多业务板块分化调整","url":"https://stock-news.laohu8.com/highlight/detail?id=1163269424","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163269424?lang=zh_cn&edition=full","pubTime":"2026-04-24 21:49","pubTimestamp":1777038585,"startTime":"0","endTime":"0","summary":"昊海生物科技于本报告年度实现收入人民币24.46亿元，同比下降约8.7%。同期毛利为人民币17.12亿元，与上年度的18.69亿元相比亦有回落。全年归属于母公司拥有人的净利润为人民币2.51亿元，降幅达40.3%。公司现金流方面，经营活动所得现金净额为人民币4.91亿元，较上年同期减少24.29%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"昊海生物科技2025年收入下滑至24.46亿元 多业务板块分化调整","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629844997","title":"昊海生物科技(06826)提名田敏为公司执行董事候选人","url":"https://stock-news.laohu8.com/highlight/detail?id=2629844997","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629844997?lang=zh_cn&edition=full","pubTime":"2026-04-24 21:09","pubTimestamp":1777036180,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，公司于 2026年4月24日召开公司董事会会议审议通过，其中包括，提名田敏女士为公司执行董事候选人，以及分别提名陈少瑜先生、宋渊洋先生及许多奇女士为公司独立非执行董事候选人的议案。彼等候选人任期自公司股东于2025年年度股东会上批准之日起，至第六届董事会任期届满止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433711.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06826","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629087757","title":"【券商聚焦】中信建投：医疗器械板块拐点来临 26年业绩改善个股存在业绩估值修复机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2629087757","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629087757?lang=zh_cn&edition=full","pubTime":"2026-04-21 09:19","pubTimestamp":1776734371,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投研究认为，医疗器械板块拐点已经来临，26年业绩改善个股存在业绩估值修复机会。建议持续关注市场空间大、国产化率低的创新器械赛道，以及并购重组、脑机接口、AI医疗、手术机器人、外骨骼机器人等主题方向的投资机会。潜在催化较多的方向有望出现涨幅数倍的个股，未来AI医疗、脑机接口等也有望成为投资人重点关注的新科技方向。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1979495","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1617","01066","BK1584","02252","BK1222","BK1615","BK1591","LU0173614495.USD","BK1610","LU0287142896.SGD","02235","159883","BK1587","BK1247","BK0276","00241","BK1100","BK1593","02190","BK1600","BK1515","BK1585","BK1571","09996","BK1574","BK1502","BK1142","BK1589","BK1189","BK1583","BK1161","09997","01302","601066","00853","BK1501","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150573291","title":"昊海生物科技2026年3月股份变动月报，购回H股580,700股","url":"https://stock-news.laohu8.com/highlight/detail?id=1150573291","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150573291?lang=zh_cn&edition=full","pubTime":"2026-04-02 15:41","pubTimestamp":1775115679,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司于2026年4月2日披露2026年3月股份变动月报。报告期为2026年3月1日至3月31日。截至2026年3月31日，公司注册股本总计229,980,895股，其中A股194,051,855股，H股35,929,040股。本月内，公司通过购回方式减少580,700股H股，同时另行购回的121,800股H股截至月末尚未注销。报告期内未出现新增股份发行、股权激励或可换股票据等其他影响股本的变动。上述月报由联席公司秘书田敏签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622818008","title":"【券商聚焦】中信建投：医疗器械板块拐点来临，26年业绩改善个股存在业绩估值修复机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2622818008","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622818008?lang=zh_cn&edition=full","pubTime":"2026-03-26 09:18","pubTimestamp":1774487918,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投表示，医疗器械板块拐点来临，26年业绩改善个股存在业绩估值修复机会。建议持续关注市场空间大、国产化率低的创新器械赛道，以及并购重组、脑机接口、AI医疗、手术机器人、外骨骼机器人等主题方向的投资机会。潜在催化较多的方向有望出现涨幅数倍的个股，未来AI医疗、脑机接口等也有望成为投资人重点关注的新科技方向。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977292","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853","BK1247","BK1615","BK1617","BK1583","BK1591","01066","LU0173614495.USD","09996","BK1610","BK1571","01302","BK1100","BK0276","601066","LU0287142896.SGD","09997","159883","BK1142","BK1589","BK1593","BK1501","00241","02235","02252","BK1161","BK1222","BK1587","BK1584","06826","BK1189","BK1574","BK1502","BK1515","02190","BK1585","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127601958","title":"昊海生物科技：3月24日回购14,600股H股，涉资332,344港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1127601958","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127601958?lang=zh_cn&edition=full","pubTime":"2026-03-24 17:12","pubTimestamp":1774343529,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司于2026年3月24日发布公告，披露当日在香港联交所场内回购14,600股H股，回购价格区间每股22.60港元至23.06港元，合计付出价格332,344港元。本次回购股份数量约占公司当前已发行普通股总数的0.0065%，完成后公司H股发行总数仍为35,929,040股。回购授权于2025年6月10日获得股东大会通过，授权回购股份总数为3,914,184股。截至目前，公司已累计回购2,722,000股，占回购授权通过时公司已发行股本的6.9542%。本次公告由公司董秘兼联席公司秘书田敏签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190911143","title":"昊海生物科技3月23日回购10.72万股，耗资约240.55万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1190911143","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190911143?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:36","pubTimestamp":1774258585,"startTime":"0","endTime":"0","summary":"2026年3月23日，昊海生物科技公布回购股份事项。公司当日在香港联交所场内回购H股共计107,200股，约占公司现有已发行股份总数的0.0474%。本次回购价格介乎每股22.28港元至22.68港元，总涉资约240.55万港元。公告显示，公司已发行股份总数目前为226,132,800股，其中包括190,203,760股A股与35,929,040股H股。此外，公司于2025年6月10日通过的购回授权所允许回购的股份总数为3,914,184股，截至目前已回购2,707,400股。公司确认，此次回购符合法律法规及上市规则的相关规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621501771","title":"昊海生物科技(06826)3月23日耗资约240.55万港元回购10.72万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621501771","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621501771?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:32","pubTimestamp":1774258365,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)公布，2026年3月23日耗资约240.55万港元回购10.72万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417421.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","06826","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620737311","title":"昊海生物科技(06826)将派发末期股息每股0.6元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620737311","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620737311?lang=zh_cn&edition=full","pubTime":"2026-03-20 22:51","pubTimestamp":1774018266,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，将派发截至2025年12月31日止年度末期股息每股0.6元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416971.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","VIG","BK1161","06826","BK4585","BK1593"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3healthcare.com/","stockEarnings":[{"period":"1week","weight":0.0346},{"period":"1month","weight":0.0018},{"period":"3month","weight":-0.1466},{"period":"6month","weight":-0.1927},{"period":"1year","weight":-0.0609},{"period":"ytd","weight":-0.0934}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0399},{"period":"3month","weight":-0.0588},{"period":"6month","weight":-0.005},{"period":"1year","weight":0.1653},{"period":"ytd","weight":0.0057}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海昊海生物科技股份有限公司是一家主要从事生产及销售生物制品、医用透明质酸及人工晶状体、研发生物工程及药品及提供相关服务的中国公司。眼科业务已覆盖白内障治疗、近视防控与屈光矫正及眼表用药、提供人工晶状体及角膜塑形镜等产品的视光材料。医疗美容与创面护理产品覆盖玻尿酸真皮填充剂、皮肤和黏膜浅层组织补充用透明质酸凝胶等。骨科产品包含骨科关节腔黏弹补充剂等。防黏连及止血产品包括医用几丁糖（防黏连用）、医用透明质酸钠凝胶和胶原蛋白海绵。该公司主要在国内外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.002083},{"month":2,"riseRate":0.363636,"avgChangeRate":0.018828},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.014554},{"month":4,"riseRate":0.818182,"avgChangeRate":0.062964},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.008144},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.008696},{"month":7,"riseRate":0.545455,"avgChangeRate":0.056614},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.023358},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.016752},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.029245},{"month":11,"riseRate":0.545455,"avgChangeRate":-0.009618},{"month":12,"riseRate":0.545455,"avgChangeRate":0.02266}],"exchange":"SEHK","name":"昊海生物科技","nameEN":"HAOHAI BIOTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昊海生物科技(06826)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昊海生物科技(06826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昊海生物科技,06826,昊海生物科技股票,昊海生物科技股票老虎,昊海生物科技股票老虎国际,昊海生物科技行情,昊海生物科技股票行情,昊海生物科技股价,昊海生物科技股市,昊海生物科技股票价格,昊海生物科技股票交易,昊海生物科技股票购买,昊海生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昊海生物科技(06826)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昊海生物科技(06826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}